Utility of dynamic contrast-enhanced MRI to assess small bowel perfusion in paroxysmal nocturnal hemoglobinuria before and after eculizumab

Eur J Intern Med. 2018 Nov:57:e25-e27. doi: 10.1016/j.ejim.2018.08.005. Epub 2018 Aug 17.

Authors

Wilma Barcellini¹, Giulio Pezzetti², Bruno Fattizzo³, Francesca Cavallaro³, Francesco De Cobelli²

Affiliations

¹ Hematology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: wbarcel@policlinico.mi.it.
² Department of Radiology, Centre for Experimental Imaging, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
³ Hematology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

PMID: 30126686
DOI: 10.1016/j.ejim.2018.08.005

No abstract available

Keywords: Eculizumab; Magnetic resonance imaging; Paroxysmal nocturnal hemoglobinuria; Thrombosis.

Publication types

Letter

MeSH terms

Adolescent
Antibodies, Monoclonal, Humanized / therapeutic use*
Female
Hemoglobinuria, Paroxysmal / diagnostic imaging
Hemoglobinuria, Paroxysmal / drug therapy*
Humans
Intestine, Small / blood supply*
Intestine, Small / diagnostic imaging
Magnetic Resonance Imaging*
Young Adult

Substances

Antibodies, Monoclonal, Humanized
eculizumab